Integral Molecular’s DENV Neutralization Kit is an all-in-one solution for easy neutralization assays using replication-incompetent virus-like-particles. The kit includes Reporter Virus Particles for all four dengue serotypes and BHK DC-SIGN cells.
Catalog Number | Product | Strain | Unit |
RVP-101L | Dengue Serotype 1 Reporter Virus Particles | 16007 | 1 vial (1 mL) |
RVP-201L | Dengue Serotype 2 Reporter Virus Particles | 16681 | 1 vial (1 mL) |
RVP-301L | Dengue Serotype 3 Reporter Virus Particles | 16562 | 1 vial (1 mL) |
RVP-401L | Dengue Serotype 4 Reporter Virus Particles | TVP360 | 1 vial (1 mL) |
C-BD101 | BHK DC-SIGN Stable Cell Line | -- | 1 vial (3e6 cells) |
Reporter Virus Particles (RVPs) for all four dengue serotypes are replication-incompetent virus-like-particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation.
DENV RVPs are used to test the ability of serum, antibodies, and drugs to neutralize infectivity. DENV RVPs are structurally intact dengue virus-like particles, capable of a single round of infection and carry a genome that expresses a luciferase optical reporter gene upon infection. RVPs are derived from a baby hamster kidney cell line (BHK-21) and are produced using DENV CprME structural genes and a Flavivirus reporter replicon.
C-BD101 is a monoclonal cell line generated using BHK baby hamster kidney cells to create a permissive cell line for infection by flavivirus Reporter Virus Particles. The cells were developed from BHK21 clone 15 (Center for Vector-borne Diseases, UC Davis). The cells are adherent and have a fibroblast morphology.
Cells are intended for research purposes only. Protocols are provided for neutralization and infectivity assays.
Product | Neutralization Kit - Dengue 1-4 Reporter Virus Particles |
Catalog Number | KIT-401L |
Strain | DENV1-4 |
Packaging | 20% FBS/DMEM |
Recommended Input Range | 1-2 uL per well (96-well plate) using the BHK DC-SIGN stable cell line |
Lead time | Ready to ship |
Shipping | Shipped on dry ice |
Storage conditions | Store at -80°C (+/- 10°C) upon receipt |
Size | 5 total vials |
Warranty | Terms and Conditions (pdf) |
SDS | |
Protocols |
|
Technical Data Sheets |
Integral Molecular’s products for dengue neutralization assays have been cited in leading publications for over a decade, describing both vaccine and therapeutic antibody development. Example publications include:
- Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine DeMaso et al. 2022 J Infect Dis 226, 11
- Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infectionValiant et al. 2018 Emerg Microbes Infect. 7, 130
- Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort Katzelnick et al. 2016 Proc. Natl. Acad. Sci. U.S.A. 113, 3
- Dengue Reporter Virus Particles for Measuring Neutralizing Antibodies against Each of the Four Dengue Serotypes Mattia et al. 2011 PLoS ONE 6(11), e27252